Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Relief Therapeutics Holding AG Stock

Price
Target price
?

?

-10.000%
-0.024
-10.000%
-

-

 
Buy 0 Sell 0
Buy 0
Sell 0
19.08.26 / Frankfurt WKN: A3EFB5 / Name: Relief Therapeutics Holding / Stock / ? /
Your prediction
Pros and Cons of Relief Therapeutics Holding AG in the next few years
Wizard

Relief Therapeutics Holding AG Stock

Relief Therapeutics Holding AG took a tumble today and lost -€0.024 (-10.000%).
What does Relief Therapeutics Holding do?

Pros and Cons of Relief Therapeutics Holding AG in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice
Register To Post

News

MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
eqs_en 
0 12.08.26
MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
eqs_en 
0 10.08.26
MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy
MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy
MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy
eqs_en 
0 09.07.26